The immunogenicity and reactogenicity of the trivalent vaccine, Trimovax, indicated for prevention of measles, mumps, and rubella, in 12-month-old children in Belarus.

Autor: Samoilovich EO; Research Institute for Epidemiology and Microbiology, Public Health Ministry of the Republic of Belarus, Minsk, Belarus., Kapustik LA, Feldman EV, Yermolovich MA, Svirchevskaya AJ, Zakharenko DF, Fletcher MA, Titov LP

Publikováno v: Central European journal of public health [Cent Eur J Public Health] 2000 Aug; Vol. 8 (3), pp. 160-3.